https://www.selleckchem.com/products/dasa-58.html
In multivariate analysis, patients with spinal metastasis had better OS compared to their counterparts, and patients who received single-fraction SBRT had better PFS than those who did not. No patient experienced acute or late toxicities of grade3 or greater. Despite excellent LC at the oligometastatic site treated with SBRT, disease progression was observed in nearly half of patients 13months after metastasis-directed local therapy, particularly as distant disease progression other than the treated lesion, necessitating an effective sy
Like
Comment
Share
